SteroTherapeutics
- Spring House, Pennsylvania, United States
SteroTherapeutics Employees
SteroTherapeutics Senior Management
SteroTherapeutics Details
SteroTherapeutics is pursuing a novel drug therapy for Non-alcoholic steatohepatitis (NASH) which has been predicted as the next major health epidemic. The situation is paramount as NASH has no approved treatments and is a leading cause of liver related morbidity and mortality. Analysts are forecasting that the market for NASH treatment could reach $35-$40 Billion by 2025.
Website:
http://www.sterotx.com
Employees:
0
HQ:
(267) 300-0010
Location:
Spring House, Pennsylvania, United States
Revenue:
SteroTherapeutics Technologies
Load Balancers
Varnish
CMS
Wix
Hosting
Google Cloud Hosting
Other
Mobile Friendly
CSS and JavaScript Libraries
Bootstrap Framework